ORMP Oramed Pharmaceuticals Inc.

Fundamentals / CIK 0001176309 / USD

Oramed Pharmaceuticals Inc. reported $2.00M in revenue and net income of $144.9M for the fiscal year ended December 31, 2025, with a 0.7% gross margin and a -810.1% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ORMP in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$66.99M$33.49M$0-$39.63MFY 2016 Revenue: $641KFY 2016 Net Income: -$10.96M2016FY 2017 Revenue: $2.46MFY 2017 Net Income: -$10.48M2017FY 2018 Revenue: $2.45MFY 2018 Net Income: -$12.73M2018FY 2019 Revenue: $2.70MFY 2019 Net Income: -$14.36M2019FY 2020 Revenue: $2.71MFY 2020 Net Income: -$11.51M2020FY 2021 Revenue: $2.70MFY 2021 Net Income: -$22.99M2021FY 2022 Revenue: $2.70MFY 2022 Net Income: -$36.56M2022FY 2023 Revenue: $1.34MFY 2023 Net Income: $5.09M2023FY 2024 Net Income: -$19.06M2024FY 2025 Revenue: $2.00MFY 2025 Net Income: $64.05M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31
Revenue $2.00M -- $1.34M $2.70M $2.70M $2.71M $2.70M $2.45M $2.46M $641K
Cost of Revenue $1.99M -- -- -- -- -- $90K -$86K $187K $490K
Gross Profit $13K -- -- -- -- -- $2.61M $2.54M $2.27M $151K
Research & Development $6.38M $6.32M $8.97M $27.64M $20.99M $10.23M $13.52M $11.98M $10.28M $7.71M
Operating Income -$15.09M -$12.78M -$15.77M -$40.60M -$24.22M -$11.76M -$14.63M -$13.53M -$10.77M -$10.01M
EBITDA -$14.97M -$12.59M -$15.57M -$40.54M -$24.15M -$11.75M -$14.62M -$13.52M -$10.77M -$10.01M
Interest Income $2.37M $4.98M $10K $100K -- -- -- -- -- --
Interest Expense -- $853K $2.04M -- -- -- -- -- -- --
Income Before Tax $75.32M -$15.92M $5.09M -$37.66M -- -$11.51M -$14.05M -$12.73M -$10.08M -$9.63M
Income Tax Expense $11.31M $3.18M -- $100K -- -- $300K -- $400K $1.33M
Net Income $64.05M -$19.06M $5.09M -$36.56M -$22.99M -$11.51M -$14.36M -$12.73M -$10.48M -$10.96M
Basic EPS $1.53 -$0.48 $0.14 -$0.94 $0.78 $0.56 $0.82 $0.86 $0.79 $0.87
Diluted EPS $1.50 -$0.48 $0.14 -$0.94 $0.78 $0.56 $0.82 $0.86 $0.79 $0.87
Basic Shares Outstanding 41.4M 40.9M 40.3M 39.0M 28.5M 20.5M 17.5M 14.9M 13.3M 12.6M
Diluted Shares Outstanding 42.4M 40.9M 40.6M 39.0M 28.5M 20.5M 17.5M 14.9M 13.3M 12.6M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue -- -- -- $0 $0 $0 $2.00M --
Cost of Revenue -- -- -- $0 $0 $0 $1.99M --
Gross Profit -- -- -- $0 $0 $0 $13K --
Research & Development $0 $0 $1.59M $1.99M $1.15M $1.03M $2.21M $1.46M
Operating Income -$4.10M -$2.77M -$3.66M -$5.67M -$2.43M -$2.49M -$4.50M -$3.60M
EBITDA -$4.07M -$2.73M -$3.63M -$5.64M -$2.40M -$2.46M -$4.47M -$3.56M
Interest Income $150K $98K $276K $238K $510K $802K $647K --
Interest Expense -- -- -- -- -- -- -- $0
Income Before Tax $28.28M $101.6M $49.44M $9.80M $59.45M $13.13M -$7.06M -$9.78M
Income Tax Expense $9.87M $23.43M $11.13M -$212K $11.06M -$126K $584K --
Net Income $18.41M $78.16M $38.31M $10.01M $48.40M $13.29M -$7.64M -$10.19M
Basic EPS $0.44 $1.90 $0.94 -- $1.16 $0.32 -$0.19 --
Diluted EPS $0.43 $1.84 $0.91 -- $1.13 $0.31 -$0.19 --
Basic Shares Outstanding 41.7M 41.0M 40.8M -- 41.8M 41.7M 41.2M --
Diluted Shares Outstanding 43.0M 42.5M 42.0M -- 42.8M 42.6M 41.2M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31
Cash & Cash Equivalents $45.95M $54.42M $9.05M $40.46M -- $77.25M $19.30M $3.33M $5.00M $3.97M
Short-Term Investments $5.42M $3.44M $57.71M $3.74M $7.75M $5.85M $3.30M $3.70M $4.59M $2.86M
Cash & Short-Term Investments $51.36M $57.86M $66.77M $44.21M -- $83.10M $22.59M $7.03M $9.59M $6.83M
Total Current Assets $133.3M $143.2M $162.6M $157.1M $147.9M $95.34M $40.51M $33.32M $31.04M $20.30M
Property, Plant & Equipment, Net $586K $698K $873K $815K $388K $397K $99K $24K $17K $18K
Long-Term Investments $8.37M $3.52M $1.81M $2.70M $3.88M $6.69M $3.93M $1.29M $13.54M $1.0K
Other Non-Current Assets $44K $32K $27K -- -- -- -- -- -- --
Total Non-Current Assets $97.59M $12.06M $57.97M $4.53M $29.88M $32.66M $4.12M $1.34M $16.36M $18.41M
Total Assets $230.9M $155.3M $220.6M $161.6M $177.8M $128.0M $44.63M $34.66M $47.40M $38.71M
Accounts Payable $443K $789K $551K $2.17M $1.69M $2.61M $594K $1.34M $1.14M $571K
Short-Term Debt -- -- $51.01M -- -- -- -- $2.70M $2.45M --
Deferred Revenue (Current) $1.35M -- -- $1.34M $2.00M -- $2.70M $2.70M $2.45M $2.45M
Other Current Liabilities $1.71M $1.37M $59K $133K -- $243 -- -- -- --
Total Current Liabilities $19.09M $5.68M $53.21M $5.75M $7.37M $6.68M $4.54M $5.31M $4.55M $5.17M
Long-Term Debt -- -- -- $25K $11.62M $12.54M -- -- -- --
Deferred Revenue (Non-Current) $2.00M $4.00M $4.00M $4.00M $3.34M $4.24M $6.95M $9.66M $11.39M $13.84M
Other Non-Current Liabilities -- $60K $63K -- -- -- $211K $271K $313K $443K
Total Non-Current Liabilities $12.03M $4.25M $4.44M $4.74M $3.84M $4.80M $7.22M $9.96M $11.73M $14.31M
Total Liabilities $31.12M $9.93M $57.66M $10.49M $11.21M $11.48M $11.75M $15.27M $16.29M $19.47M
Total Debt (incl. Leases) $825K $372K $51.62M $919K $12.12M $13.08M $31K $2.70M $2.45M --
Common Stock $472K $480K $485K $476K $459K $424K $284K $208K $207K $163K
Retained Earnings -$123.4M -$176.6M -$157.6M -$163.1M -$126.5M -$114.9M -$92.61M -$81.10M -$69.22M -$56.50M
Accumulated Other Comp. Income -- -- -- -- -- -- -- -- $702K $401K
Total Stockholders' Equity $199.7M $146.3M $163.8M $151.8M $166.5M $115.8M $32.88M $19.39M $31.11M $19.24M
Total Equity $199.7M $145.3M $162.9M $151.2M $166.6M $116.5M $32.88M $19.39M $31.11M $19.24M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents -- $15.24M $13.20M $45.95M $52.18M $15.80M -- $54.42M
Short-Term Investments $583K $846K $4.96M $5.42M $4.96M $1.75M $3.69M $3.44M
Cash & Short-Term Investments -- $16.09M $18.17M $51.36M $57.13M $17.55M -- $57.86M
Total Current Assets $57.38M $53.41M $68.15M $133.3M $136.1M $99.03M $131.5M $143.2M
Property, Plant & Equipment, Net $506K $532K $561K $586K $614K $645K $671K $698K
Long-Term Investments $10.80M $21.87M $17.97M $8.37M -- -- $3.52M $3.52M
Other Non-Current Assets $46K $49K $46K $44K $40K $38K $32K $32K
Total Non-Current Assets $343.5M $316.2M $200.7M $97.59M $84.38M $62.66M $16.06M $12.06M
Total Assets $400.9M $369.6M $268.8M $230.9M $220.5M $161.7M $147.5M $155.3M
Accounts Payable $125K $374K $481K $443K $560K $715K $509K $789K
Deferred Revenue (Current) $1.51M $1.71M $1.47M $1.35M -- -- -- --
Other Current Liabilities -- -- -- $1.71M -- -- -- $1.37M
Total Current Liabilities $9.45M $10.73M $10.56M $19.09M $6.12M $3.69M $5.49M $5.68M
Deferred Revenue (Non-Current) -- -- -- $2.00M $2.00M $2.00M $2.00M $4.00M
Other Non-Current Liabilities -- -- -- -- -- -- -- $60K
Total Non-Current Liabilities $52.39M $41.44M $20.01M $12.03M $12.04M $4.41M $2.15M $4.25M
Total Liabilities $61.83M $52.17M $30.57M $31.12M $18.16M $8.10M $7.64M $9.93M
Total Debt (incl. Leases) $1.53M $733K $761K $825K $860K $912K $301K $372K
Common Stock $519K $495K $491K $472K $490K $491K $491K $480K
Retained Earnings $11.45M -$6.96M -$85.12M -$123.4M -$122.6M -$171.0M -$184.3M -$176.6M
Total Stockholders' Equity -- -- -- $199.7M $203.3M $154.5M $140.8M $146.3M
Total Equity $339.1M $317.5M $238.3M $199.7M $202.3M $153.6M $139.9M $145.3M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31
Net Income $64.02M -$19.10M $5.53M -$37.76M -$22.99M -$11.51M -$14.36M -$12.73M -$10.48M -$10.96M
Depreciation & Amortization $121K $193K $196K $58K $77K $7.0K $8.0K $6.0K $5.0K $4.0K
Stock-Based Compensation $5.99M $4.05M $4.21M $11.51M $2.69M $465K $808K $1.55M $1.57M $634K
Operating Cash Flow -$9.14M -$8.41M -$10.29M -$27.92M -$21.18M -$12.44M -$12.94M -$14.66M -$5.83M $4.66M
Capital Expenditure -$9.0K -$18K -$254K -$496K -$375K -$82K -$15K -$5.0K -$7.0K -$9.0K
Free Cash Flow -$9.15M -$8.43M -$10.55M -$28.41M -$21.56M -$12.52M -$12.96M -$14.66M -$5.84M $4.65M
Purchases of Investments -$9.85M -$1.31M -$99.55M -- -- -- -- -- -- --
Investing Cash Flow $5.44M $105.8M -$73.04M $30.21M -$23.76M $4.63M $11.26M -$7.00M $4.30M -$16.01M
Common Stock Issued -- -- $2.43M $11.50M $10.62M -- -- $21.66M $25K $10.59M
Share Repurchases -$4.74M -$2.48M -- -- -- -- -- -- -- --
Financing Cash Flow -$4.74M -$52.04M $51.98M $10.78M $102.9M $23.79M -- $22.65M $1.59M $12.04M
Net Change in Cash -$8.47M $45.37M -$31.41M $13.01M $57.95M $15.97M -$1.67M $1.03M $62K $694K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income $18.41M $78.16M $38.31M $10.01M $48.39M $13.26M -$7.64M -$10.20M
Depreciation & Amortization $30K $31K $30K $30K $31K $30K $30K $31K
Stock-Based Compensation $3.11M $1.39M $1.74M $2.28M $719K $800K $2.19M $1.23M
Operating Cash Flow $426K -$200K -$2.92M -$466K -$1.62M -$3.54M -$3.52M -$1.91M
Capital Expenditure -$4.0K -$2.0K -$5.0K -$2.0K $0 -$4.0K -$3.0K -$11K
Free Cash Flow $422K -$202K -$2.92M -$468K -$1.62M -$3.54M -$3.52M -$1.92M
Purchases of Investments -$4.21M -$8.73M -$12.86M -- -- -$755K -$1.19M --
Investing Cash Flow $13.19M $4.31M -$19.49M -$1.68M $38.36M -$54.85M $23.62M $15.42M
Dividends Paid -$57K -$78K -$10.36M -- -- -- -- --
Financing Cash Flow $40K -$1.95M -$10.36M -- -- -- -- -$1.20M
Net Change in Cash $13.69M $2.04M -$32.74M -$6.23M $36.38M -$58.72M $20.10M $12.32M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31 Aug 31
Gross Margin 0.7% -- -- -- -- -- 96.7% 103.5% 92.4% 23.6%
Operating Margin -754.4% -- -1176.8% -1502.0% -896.2% -433.8% -541.3% -552.3% -438.6% -1561.6%
Net Profit Margin 3202.5% -- 379.7% -1352.6% -850.5% -424.8% -531.1% -519.7% -426.7% -1710.5%
Return on Equity (ROE) 32.1% -13.0% 3.1% -24.1% -19.9% -35.0% -74.0% -40.9% -54.5% -41.9%
Return on Assets (ROA) 27.7% -12.3% 2.3% -22.6% -18.0% -25.8% -41.4% -26.9% -27.1% -25.6%
Current Ratio 6.98x 25.19x 3.06x 27.34x 14.27x 8.93x 6.28x 6.82x 3.93x 8.62x
Quick Ratio 2.69x 10.18x 1.25x 7.69x 12.44x 4.98x 1.32x 2.11x 1.32x 1.87x
Debt to Equity 0.00x 0.00x 0.32x 0.01x 0.11x 0.00x 0.14x 0.08x -- --
Revenue Growth (YoY) -- -- -50.4% -- -0.3% +0.3% +10.4% -0.3% +283.2% --
Gross Profit Growth (YoY) -- -- -- -- -- -- +3.1% +11.7% +1402.6% --
Net Income Growth (YoY) -- -474.6% -- -- -- -- -- -- -- --
EPS Growth (YoY) -- -442.9% -- -- +39.3% -31.7% -4.7% +8.9% -9.2% +29.9%
Operating Cash Flow Growth (YoY) -- -- -- -- -- -- -- -- -225.3% --
Free Cash Flow Growth (YoY) -- -- -- -- -- -- -- -- -225.7% --
5Y Revenue / Share Growth -- -- -- -- +87.0% -- -- -- -- --
5Y Net Income / Share Growth -- -- -- -- -- -- -- -245.7% -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin -- -- -- 0.7% -- -- -- --
Operating Margin -- -- -- -754.4% -- -- -- --
Net Profit Margin -- -- -- 3202.5% -- -- -- --
Return on Equity (ROE) -- -- -- 32.1% 21.6% -15.6% -20.1% -13.0%
Return on Assets (ROA) 36.1% 47.3% 40.9% 27.7% 19.9% -14.9% -19.1% -12.3%
Current Ratio 6.07x 4.98x 6.45x 6.98x 22.24x 26.81x 23.94x 25.19x
Quick Ratio -- 1.50x 1.72x 2.69x 9.34x 4.75x -- 10.18x
Debt to Equity -- -- -- 0.00x 0.00x 0.01x 0.00x 0.00x
Net Income Growth (YoY) -62.0% +488.2% -- -- -- +44.2% -597.5% -179.0%
EPS Growth (YoY) -62.1% +493.7% -- -- -- +45.5% -575.0% --
Operating Cash Flow Growth (YoY) -- -- -- -- -- -270.3% -- --
Free Cash Flow Growth (YoY) -- -- -- -- -- -270.5% -- --
Source: SEC EDGAR CompanyFacts (CIK 0001176309) · from August 31, 2008 Data through September 30, 2026 · synced Nov 20, 2026, 05:46 UTC · Open in terminal